First-ever phase-three clinical trial for dengue vaccine initiated in India – Deccan Herald

First-ever phase-three clinical trial for dengue vaccine initiated in India  Deccan HeraldPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins  UpstoxICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll  MintICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine  ETHealthWorldICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India  Moneycontrol First-ever phase-three clinical trial for dengue vaccine initiated in India  Deccan HeraldPanacea Biotec shares up 5% as phase-3 trial of India’s first dengue vaccine ‘DengiAll’ begins  UpstoxICMR and Panacea Biotec begin Phase 3 clinical trial of India’s 1st indigenous dengue vaccine DengiAll  MintICMR, Panacea Biotec begin Phase 3 clinical trial of indigenous dengue vaccine  ETHealthWorldICMR, Panacea Biotec initiate 1st ever phase-three clinical trial for dengue vaccine in India  Moneycontrol  Top stories – Google News